Indirectly, oncogenic Rho GTPase signaling activates JNK (c-Jun N-terminal kinase), which phosphorylates and stabilizes c-Jun, forming a coherent JNK/c–Jun/GLS promoter axis that amplifies GLS expression and promotes glutamine metabolism in breast cancer cells (90). Here, JUN is linked to breast carcinoma.